FDA Likely to Approve Pfizer Booster Shots — Even if They Don’t Work — Thanks to Outdated Rules Favoring Drug Companies
‘There Is a Real Cost’: as COVID Shows, Barring Bedside Visitors From ICU Deprives Patients of the Best Care
